UltraSpect, provider of the only multi-vendor and most cost-effective imaging solution for meeting the American Society of Nuclear Cardiology (ASNC) low dose guidelines, announces today that Henry Ford Wyandotte Hospital in Michigan has upgraded its nuclear medicine (NM) image reconstruction software to UltraSpect Xpress3.Cardiac. As a result, all patients receiving NM exams now have exams in half the time, with half the dose, regardless of the model or age of camera being used.

The practice of radiation oncology is advancing rapidly, but even as the technology evolves, it is the power of partnership that is key to improving care. Novel collaboration with radiology, payers and the patients themselves are changing the way treatments are delivered.

An annual financial report from Advanced Accelerator Applications (AAA) in Saint-Genis-Pouilly, France, announced yesterday that the company’s sales were up just over 30 percent to almost $80 million.

Protea Biosciences based in West Virginia and Swiss biotech firm InSphero announced this week that the companies are combining their 3D technologies into one preclinical imaging platform.

CT is the workhorse of imaging, but as utilization surged in the new millennium, so did concerns about radiation dose. 

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has given an encouraging nod toward final approval for European marketing of the amyloid-aiming PET agent F-18 flutemetamol (Vizamyl).

Konica Minolta Medical Imaging, a world-class provider and market leader in medical diagnostic Primary Imaging Solutions, announced today a partnership with SonoSim to provide an integrated ultrasound training solution for the SONIMAGE P3 hand-held ultrasound system.

This week, U.S. District Judge Anita Brody gave preliminary approval to a settlement deal to compensate retired NFL players dealing with the long-term consequences of head injuries sustained during their playing days.